Social engagement
Social engagement: 232 social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
13 investors on record; lead investors include Eight Roads Ventures, F-Prime Capital, JIC Venture Growth Investments, Newton Biocapital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 11 | 85% |
| Other / undisclosed | 2 | 15% |
Recent activity
16 Jun 2026
Product launch
Uniphar
20 Apr 2026
Product launch
JPH034 Phase 1 Clinical Trial
13 Apr 2026
Event
Advancing Understanding of the Global Phase 3 Trial of Nanvuranlat